Polyclonal expansion of T cells with the TCR Vβ type of the tumour cell in lesions of cutaneous T-cell lymphoma: Evidence for possible superantigen involvement

British Journal of Dermatology

Volumn 150, Issue 5, 2004, Pages 1013-1017

  Linnemann, T ^a   Gellrich, S ^a   Lukowsky, A ^a   Mielke, A ^a   Audring, H ^a   Sterry, W ^a   Walden, P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cancer; CTCL; Lymphoma; Superantigen; T cell receptor; T lymphocyte

Indexed keywords

SUPERANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; CELL CLONING; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; GENE REARRANGEMENT; HUMAN; HUMAN CELL; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; CASE REPORT; CELL CULTURE; EPIDERMIS; IMMUNOLOGY; MYCOSIS FUNGOIDES; SKIN TUMOR; T LYMPHOCYTE SUBPOPULATION;

EPIDERMIS; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; MYCOSIS FUNGOIDES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SKIN NEOPLASMS; SUPERANTIGENS; T-LYMPHOCYTE SUBSETS; TUMOR CELLS, CULTURED;

EID: 3042744087     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.05970.x     Document Type: Article

References (25)

1. Willemze R, Kerl H, Sterry W et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90: 354-71.
2. Sterry W. Mycosis fungoides. Curr Top Pathol 1985; 74: 167-223.
3. Kung PC, Berger CL, Goldstein G et al. Cutaneous T cell lymphoma: characterization by monoclonal antibodies. Blood 1981; 57: 261-6.
4. Freedman AS, Nadler LM. Immunologic markers in non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 1991; 5: 871-89.
5. Sterry W, Mielke V. CD4+ cutaneous T-cell lymphomas show the phenotype of helper/inducer T cells (CD45RA-, CDw29+). J Invest Dermatol 1989; 93: 413-16.
6. Charley M, McCoy JP, Deng JS, Jegasothy B. Anti-V region antibodies as 'almost clonotypic' reagents for the study of cutaneous T cell lymphomas and leukemias. J Invest Dermatol 1990; 95: 614-17.
7. Boehncke WH, Krettek S, Parwaresch MR, Sterry W. Demonstration of clonal disease in early mycosis fungoides. Am J Dermatopathol 1992; 14: 95-9.
8. McHenry PM, Campbell I, Mackie RM. Assessment of an anti-T-cell receptor variable region antibody panel in cutaneous T-cell lymphoma. Br J Dermatol 1994; 130: 595-8.
9. Gorochov G, Bachelez H, Cayuela JM et al. Expression of V beta gene segments by Sezary cells. J Invest Dermatol 1995; 105: 56-61.
10. Finn DT, Jaworsky C, Chooback L et al. Correlation between clonotypic T-cell receptor beta chain variable region (TCR-V beta) gene expression and aberrant T-cell antigen expression in cutaneous T-cell lymphoma. J Cutan Pathol 1996; 23: 306-11.
11. Potoczna N, Boehncke WH, Nestle FO et al. T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skin. J Cutan Pathol 1996; 23: 298-305.
12. Lukowsky A, Richter S, Dijkstal K et al. A T-cell receptor gamma polymerase chain reaction assay using capillary electrophoresis for the diagnosis of cutaneous T-cell lymphomas. Diagn Mol Pathol 2002; 11: 59-66.
13. Gellrich S, Lukowsky A, Schilling T et al. Microanatomical compartments of clonal and reactive T cells in mycosis fungoides: molecular demonstration by single cell polymerase chain reaction of T cell receptor gene rearrangements. J Invest Dermatol 2000; 115: 620-4.
14. Tan RS, Butterworth CM, McLaughlin H et al. Mycosis fungoides - a disease of antigen persistence. Br J Dermatol 1974; 91: 607-16.
15. Jackow CM, Cather JC, Hearne V et al. Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion. Blood 1997; 89: 32-40.
16. Burg G, Kempf W, Haeffner A et al. From inflammation to neoplasia: new concepts in the pathogenesis of cutaneous lymphomas. Recent Results Cancer Res 2002; 160: 271-80.
17. Tokura Y, Yagi H, Ohshima A et al. Cutaneous colonization with staphylococci influences the disease activity of Sezary syndrome: a potential role for bacterial superantigens. Br J Dermatol 1995; 133: 6-12.
18. Tokura Y, Heald PW, Yan SL, Edelson RL. Stimulation of cutaneous T-cell lymphoma cells with superantigenic staphylococcal toxins. J Invest Dermatol 1992; 98: 33-7.
19. Kotzin BL, Leung DY, Kappler J, Marrack P. Superantigens and their potential role in human disease. Adv Immunol 1993; 54: 99-166.
20. Jappe U. Superantigens and their association with dermatological inflammatory diseases: facts and hypotheses. Acta Derm Venereol 2000; 80: 321-8.
21. Musette P, Bachelez H. Cutaneous T-cell lymphomas and bacterial superantigens. Blood 1997; 90: 472-3.
22. Kaltoft K, Bisballe S, Dyrberg T et al. Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides. In Vitro Cell Dev Biol 1992; 28A: 161.
23. Kaltoft K, Bisballe S, Rasmussen HF et al. A continuous T-cell line from a patient with Sezary syndrome. Arch Dermatol Res 1985; 279: 293-8.
24. Irwin MJ, Hudson KR, Ames KT et al. T-cell receptor beta-chain binding to enterotoxin superantigens. Immunol Rev 1993; 131: 61-78.
25. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990; 248: 705-11.